Munich, Germany

Cornelius Pompe

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • München, DE (2014)
  • Munich, DE (2013 - 2022)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Cornelius Pompe: Innovator in Bispecific Antibody Constructs

Introduction

Cornelius Pompe is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibody constructs. With a total of 11 patents to his name, Pompe's work is at the forefront of innovative therapeutic solutions.

Latest Patents

Among his latest patents are the PSMA and CD3 bispecific T cell engaging antibody constructs. These inventions provide bispecific antibody constructs characterized by a specific Fc modality. The constructs include a first domain that binds to PSMA, a second domain that binds to an extracellular epitope of the human CD3ε chain, and a third domain representing the specific Fc modality. Additionally, the inventions encompass a polynucleotide encoding the antibody construct, a vector containing this polynucleotide, host cells expressing the construct, and a pharmaceutical composition comprising the same. Another significant patent involves bispecific T cell engaging antibody constructs that bind to a target cell surface antigen and the human CD3ε chain, further showcasing Pompe's innovative approach to antibody design.

Career Highlights

Cornelius Pompe has worked with prominent companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Amgen Inc. His experience in these organizations has allowed him to refine his expertise in antibody engineering and therapeutic development.

Collaborations

Throughout his career, Pompe has collaborated with notable colleagues such as Tobias Raum and Markus Münz. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Cornelius Pompe stands out as a leading inventor in the field of bispecific antibody constructs, with a strong portfolio of patents that reflect his innovative contributions to biomedicine. His work continues to pave the way for new therapeutic options in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…